Full Text
Is there an impact of the Orphan designation in Oncology on market access in Europe?

Abstract

Authors

S.C. Boiziau

Back to Volume 18, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×